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The aim of this study was to assess relationships between the fatty acid contents of plasma and 
erythrocyte phospholipids and those in liver, heart, brain, kidney and quadriceps muscle in rats. 
To obtain a wide range of tissue omega-3 (n-3) long chain polyunsaturated fatty acids (LCPUFA) 
we subjected weanling rats to dietary treatment with the n-3 LCPUFA precursor, alpha linolenic 
acid (ALA, 18:3 n-3) for 3 weeks. With the exception of the brain, we found strong and 
consistent correlations between the total n-3 LCPUFA fatty acid content of both plasma and 
erythrocyte phospholipids with fatty acid levels in all tissues. The relationships between 
eicosapentaenoic acid (EPA, 20:5n-3) and docosapentaenoic acid (DPA, 22:5 n-3) content in 
both blood fractions with levels in liver, kidney, heart and quadriceps muscle phospholipids were 
stronger than those for docosahexaenoic acid (DHA, 22:6 n-3). The strong correlations between 
the EPA+DHA (the Omega-3 Index), total n-3 LCPUFA and total n-3 PUFA contents in both 
plasma and erythrocyte phospholipids and tissues investigated in this study suggest that, under a 
wide range of n-3 LCPUFA values, plasma and erythrocyte n-3 fatty acid content reflect not only 
dietary PUFA intakes but also accumulation of endogenously synthesized n-3 LCPUFA, and 
thus can be used as a reliable surrogate for assessing n-3 status in key peripheral tissues.  
 






The omega-3 (n-3) class of fatty acids has been reported to confer a number of health benefits to 
humans [1, 2]. As a result of these health benefits, there is increasing interest in assessing the 
effects of changing the n-3 fatty acid status in animal models [3-6].  
 
The incorporation of dietary preformed or endogenously synthesized long chain polyunsaturated 
fatty acids (LCPUFA) into tissue membrane phospholipids such as brain, liver, heart and muscle 
is thought to be the mechanism to achieve the health effects of these n-3 fatty acids [7]. Although 
those tissues are important sites for metabolism, neural and structural development, collection of 
tissue samples in human and other animals is invasive and time-consuming. Blood fractions such 
as plasma and erythrocytes are readily collectable and have been used as markers for measuring 
fatty acid intakes and fatty acid metabolism in clinical trials [8-11] and animal studies [12-14]. 
However, there are relatively little information is available on the extent to which the fatty acid 
pattern of plasma or erythrocyte phospholipids correlates with the fatty acid pattern of tissue 
phospholipids after systematically supplementing dietary PUFA in a range made possible from 
existing vegetable oils. It is an important consideration since the data which exist suggest that 
different tissues accumulate fatty acids in their membrane at different rates [6, 15-17]. 
 
To obtain a wide range of tissue LCPUFA we subjected weanling rats to a range of isoenergetic 
diets varying in the level of the n-3 LCPUFA precursor, alpha linolenic acid (ALA, 18:3n-3), for 
3 weeks [3]. Here we report on the relationship between the fatty acids in the plasma and 
erythrocyte fatty acid levels and those in a range of organ tissues. The five tissues (liver, kidney, 
4 
 
heart, brain and quadriceps muscle) were selected since it is known that changed in the 
composition of their membrane can affect the functionality of the organ [18-22].  
 
2. Materials and methods 
2.1. Animals  
All procedures were performed in accordance with institutional guidelines for the use of animals 
and the Australian code of practice for the care and use of animal for scientific purposes. The 
protocol was approved by the Animal Ethics Committee, University of Adelaide (Ethics number 
S-092-2007). Twenty-five weaned male Hooded-Wistar rats were obtained from Laboratory 
Animal Services (University of Adelaide, Australia) at three weeks of age. The animals were 
group-housed (5 rats per cage) in a laboratory animal facility at thermal-neutrality (25°C) and a 
regulated humidity environment with a 12 hr light/12 hr dark cycle. The rats had free access to 
fresh water and to the experimental diets.  
 
2.2. Diets 
The diets used in the study all contained 5% fat (w/w), and the base diet was comprised of a 
modified rodent chow formulation of the AIN-93G diet (Specialty Feeds, WA, Australia). The 
isocaloric diets provided total energy of 3797 kcal per kg (15.9 MJ per kg) comprised of 67.8% 
energy (%en) of carbohydrate, 11.8%en of fat (vegetable oil) and 20.4%en of protein. The 
calculated energy content was based on the standard fuel values for protein (19.4%), fat (5%) 
and carbohydrate (64.4%) of 4, 9 and 4 kcal/g, respectively. The macronutrient content in all 
diets were as follows: sucrose 100 g/kg, casein 200 g/kg, fat 50 g/kg, starch (including 
dextrinised starch) 556 g/kg, cellulose 50 g/kg, dl-methionine 3 g/kg, AIN93 minerals 1.4 g/kg, 
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AIN93 vitamins 10 g/kg and other minerals 29.2 g/kg. The nutritional parameters were provided 
by the feed company. Five experimental diets designed to provide levels of ALA of 0.2, 0.5, 1.0, 
1.9 and 2.9%en while keeping linoleic acid (LA, 18:2 n-6) constant at 1%en were produced by 
blending different vegetable oils. Details of the composition of these diets have been published 
previously [3].  
Rats were randomly assigned to each of the five different dietary treatments (5 rats per treatment 
group). The rats were weighed at the start of the experiment, at weekly intervals during the 21 
day feeding trial and on the day of sacrifice (6 weeks of age). 
 
2.3. Blood and tissue collection 
The rats were anaesthetized with 2-5% anaesthetic agent, isoflurane (Veterinary Companies of 
Australia Pty Ltd, NSW, Australia) by inhalation in an anaesthesia induction box. Upon loss of 
responsiveness and spontaneous movement, the rats were removed from the induction box and 
continuously anaesthetized with 0.4-3% isoflurane in air-oxygen mixture with spontaneous 
respiration. 4 mL of blood was collected by intra-cardiac puncture and immediately transferred 
into tubes coated with lithium heparin (Greiner Bio-one, Kremsmunster, Austria). Plasma and 
erythrocytes were separated by centrifugation of whole blood at 1500 x g for 5 minutes. The rats 
were then killed by exsanguination and cervical dislocation whilst still unconscious. Liver, 
kidney, heart, quadriceps muscle and brain tissues were collected from each rat, placed 
immediately into chilled sample vials and frozen at -20°C for later fatty acid profiling.  
 
2.4. Lipid extraction 
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All solvents used in this study were analytical grade and were purchased from Ajax Finechem 
Pty Ltd (Auckland, New Zealand) or Chem-Supply (SA, Australia). Other chemicals and 
reagents were purchased from Sigma-Aldrich (MO, USA) unless specified otherwise. Total 
lipids from erythrocytes were extracted with chloroform/isopropanol (2:1, v/v) [23] and the total 
lipids from diets, plasma and tissues were extracted with chloroform/methanol (2:1, v/v) [24]. 
The phospholipids were separated from total lipid extracts by thin layer chromatography (TLC) 
on silica gel plates (Silica gel 60H; Merck, Darmstadt, Germany). A lipid class standard (Nu-
Chek Prep Inc, MN, USA) was run on the plates for lipid identification. The mobile phase for 
TLC was petroleum spirit/ethyl ether/glacial acetic acid (180/30/2, v/v). The TLC plates were 
sprayed with fluorescein 5-isothiocyanate in methanol, and the lipid classes were visualized 
under UV light. The phospholipid bands located at the bottom of TLC were transferred into a 
vial containing 1% (v/v) sulphuric acid (H2SO4) in methanol for transmethylation. All solvents 
used for extraction and separation contained 0.005% (w/v) of the antioxidant, butylated 
hydroxyanisol (BHA). 
 
2.5 Fatty acid methylation 
All lipids and phospholipids were transesterified with 1% (v/v) H2SO4 in methanol at 70°C for 3 
hr. After the samples were cooled, the resulting fatty acid methyl esters (FAME) were extracted 
into n-heptane and transferred into vials containing anhydrous sodium sulphate (Na2SO4).  
 
2.6 Gas chromatographic analysis of FAME 
FAME were separated and quantified by GC (Hewlett-Packard 6890, CA, USA) equipped with a 
capillary column (50 m x 0.32 mm id) coated with 0.25 μm film thickness 70% cyanopropyl 
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polysilphenylene-siloxane (BPX-70, SGC Pty Ltd, Victoria, Australia) and a flame ionisation 
detector (FID). The injector temperature was set at 250°C and the FID temperature at 300°C. The 
oven temperature at injection was initially set at 140°C and was programmed to increase to 
220°C at a rate of 5°C per minute. Helium gas was utilized as a carrier at a flow rate of 35 cm 
per second in the column and the inlet split ratio was set at 20:1. The identification and 
quantification of FAME were achieved by comparing the retention times and peak area% values 
of unknown samples to those of commercial lipid standards (Nu-Chek Prep Inc) using the 
Hewlett-Packard Chemstation data system.  
 
2.7 Statistical analysis 
A one-way analysis of variance (ANOVA) followed by Tukey-HSD test was used if P value was 
less than 0.05 and the observed data followed Gaussian distributions (calculated by the 
Kolmogorov and Smirnov test). Kruskal-Wallis post-hoc test with Dunn's multiple comparison 
test was applied for non-parametric analyses if data did not pass the normality test. A probability 
level of 0.05 (P<0.05) was used in all tests. Simple linear regression models were used to analyse 
the relationship between phospholipid fatty acid levels in tissue and both plasma and 
erythrocytes. Results are presented as Pearson correlation coefficients and regression equations 
for the correlations between fatty acid levels in plasma or erythrocytes and tissues. Correlations 
between fatty acid levels in the separate tissue and either plasma or erythrocytes were compared 
using the method of Meng et. al. [25] to determine the better predictor. Analyses were carried 
out with SAS version 9.2 (Cary, NC, USA), SPSS version 15.0 (SPSS Inc, IL, USA) and 




In this paper, we measured all the major phospholipid fatty acids for use in the regressions and 
plotted levels of 4 dominant n-3 (eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid 
(DPA, 22:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3)) and n-6 (arachidonic acid, AA, 
20:4 n-6) LCPUFA in Figure 1 and represented correlations between plasma or erythrocyte 
phospholipid n-3 LCPUFA and tissue phospholipid n-3 LCPUFA in Figure 2. 
 
3. Results 
Feeding animals a range of dietary ALA while holding the dietary LA constant at 1%en resulted 
in the anticipated wide range of LCPUFA levels in most tissues examined (Fig. 1 A-D). 
Although the overall patterns of change in fatty acid content was similar between tissues, there 
were large variations in the amount of the respective fatty acids accumulated as ALA content of 
the diet increased (Fig. 1 A-D). The extent of the change of EPA levels was highest followed by 
DPA and then DHA. The level of AA decreased in response to increases in n-3 LCPUFA (Fig. 1 
D).  
 
The correlations in key n-3 LCPUFA between plasma or erythrocyte and various organ tissues 
are shown in Figure 2. Clear linear relationships were evident between the n-3 LCPUFA in 
plasma and erythrocytes levels in a variety of organs (Fig. 2). 
 
N-3 fatty acids  
Both plasma and erythrocyte phospholipid ALA, individual n-3 LCPUFA, EPA+DHA (Omega-3 
Index), total n-3 LCPUFA and total n-3 were significantly (P<0.0001) and strongly (r=0.75-1.0) 
correlated with the corresponding fatty acids in liver, kidney, heart and quadriceps muscle 
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(Tables 1-3, 5 and Fig. 2). Slightly weaker correlations were also observed between n-3 fatty 
acid levels, with the exception of DPA, in both plasma and erythrocyte phospholipids with those 
in the brain (Tables 4 and Fig. 2). DPA levels in plasma or erythrocyte were highly correlated 
with brain DPA content (r=0.95, P<0.0001) (Table 4, Fig. 2 B and F). However, plasma and 
erythrocyte EPA (r=0.52-0.53, P<0.01) (Fig. 2 A and E), DHA (r=0.75, P<0.0001 and 0.65, 
P<0.001) (Fig. 2 C and G), Omega-3 Index (r=0.71, P<0.0001 and r=0.53, P<0.01) (Fig. 2 D and 
H), total n-3 LCPUFA (r=0.74, P<0.0001 and r=0.6, P<0.01) and total n-3 (r=0.71, P<0.0001 
and r=0.59, P<0.01) had weaker correlations with the corresponding fatty acid content in the 
brain compared with other tissues.  
 
Overall, both the erythrocyte and plasma fatty acid content was significantly correlated with the 
fatty acid content of organ tissues, however the strength of these correlations varied in a tissue-
specific manner. For example, in kidney (r=0.99), heart (r=0.99) and quadriceps muscle (r=0.99), 
tissue ALA content was more strongly correlated with the ALA content of erythrocytes than 
plasma (Tables 2, 3 and 5). The Omega-3 index, total n-3 LCPUFA and total n-3 content in the 
kidney were also more strongly correlated with erythrocyte fatty acid levels than those in plasma 
(P<0.0001) (Table 2 and Fig. 2). On the other hand, the content of these same n-3 fatty acids in 
the brain were more strongly correlated with the fatty acid content of plasma compared to 
erythrocyte phospholipids (P=0.01, 0.009 and 0.008 for Omega-3 Index, total n-3 LCPUFA and 
total n-3 respectively) (Table 4 and Fig. 2). No significant differences were observed for the 
correlations between Omega-3 Index, total n-3 LCPUFA and total n-3 in the liver, heart or 
quadriceps muscle for the two blood fractions, with an exception of the Omega-3 Index in the 
heart, for which plasma Omega-3 Index was a better predictor than the Omega-3 index in 
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erythrocytes (P=0.026). The content of all fatty acids in plasma and erythrocyte phospholipids 
were strongly correlated (Table 6). 
 
N-6 fatty acids 
The LA content of both plasma and erythrocytes was significantly correlated with the LA content 
of all tissues examined here with the exception of the quadriceps muscle (Table 5). Both plasma 
and erythrocyte AA levels were correlated with AA levels in all tissues examined, with the 
strongest correlations observed for the liver (r=0.98-0.99, P<0.0001) and the weakest correlation 
for the brain (r=0.72-0.73, P<0.0001). Plasma and erythrocyte total n-6 was significantly 
correlated with the total n-6 content of all tissues examined (Tables 1-5) 
 
In the liver and brain, the LA content in erythrocyte phospholipids was a stronger predictor of 
tissue LA levels than LA content of plasma phospholipids (r=0.88 vs 0.80 and r=0.96 vs 0.91 in 
liver and brain respectively, with P<0.05; Tables 1 and 4). Similarly, the AA content in 
erythrocyte phospholipids was a stronger predictor of AA content in the kidney than plasma AA 
content (r=0.98 vs 0.93, P=0.002) (Table 2). Erythrocyte total n-6 content was also more 
strongly correlated (P<0.0001) with liver, kidney and quadriceps muscle total n-6 levels 
compared with those in plasma phospholpids (Tables 1, 2 and 5). As expected, there were strong 
correlations between LA, AA and total n-6 levels in plasma and erythrocytes (Table 6). 
 
Monounsaturated fatty acids 
Both plasma and erythrocyte phospholipid monounsaturated fatty acids were correlated with the 
corresponding fatty acids in all tissues examined (Tables 1-3 and 5), with the exception of the 
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brain (Table 4), however the strength of these correlations was different for the two blood 
fractions. In the liver, the monounsaturated fatty acid content was more strongly correlated with 
the monounsaturated fatty acid level in plasma compared to those in erythrocytes. In contrast the 
monounsaturated fatty acid level in the plasma phospholipids was only weakly correlated with 
the monounsaturated fatty acid content of the kidney, heart and quadriceps muscle (Tables 1-3 
and 5, respectively), and were more strongly correlated with the monounsaturated fatty acid 
content in erythrocyte phospholipids. There was no correlation between the monounsaturated 
fatty acid content of either the plasma or erythrocytes and the monounsaturated fatty acids in the 
brain (Table 4). Strong correlations between total monounsaturated fatty acids in plasma and 
erythrocytes were observed (Table 6). 
 
Saturated fatty acids 
The saturated fatty acid contents of plasma or erythrocytes and tissues were within a very narrow 
range, the stable levels of total saturated fatty acids in the different tissues is shown in the lack of 
correlation values in this fatty acid type between the tissues.   
 
4. Discussion and conclusions 
The key finding of this study is that the levels of fatty acids, particularly the n-3 LCPUFA, in 
various tissue phospholipids can be predicted with confidence from plasma and erythrocyte 
phospholipid fatty acid levels. The strong (r=~0.8-1.0) and significant (all P<0.0001) 
correlations observed between n-3 PUFA and LCPUFA and erythrocyte and plasma 
phospholipids and those in liver, kidney, heart and quadriceps muscle phospholipid across a wide 
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range of fatty acid values is striking. This validates the use of blood as a surrogate for the 
changes in fatty acids in organs of animals as a result of changes in dietary fatty acids [6, 26-30]. 
 
The range of dietary ALA levels used in this study resulted in the anticipated alterations in the 
level of n-3 LCPUFA in plasma, erythrocytes and all tissue phospholipids examined. These 
findings are consistent with previous reports by our group and others that PUFA in the diet 
directly influences the fatty acid profile of blood and various tissue phospholipids in rats fed with 
vegetable oil-based diets [3, 9, 31]. The LCPUFA in tissues are thought to be mainly derived 
from endogenously fatty acid synthesis. The strong correlation between blood and tissue 
LCPUFA levels was independent of the absolute levels of LCPUFA in the tissues. For example, 
high EPA levels were found in liver and kidney while low EPA levels were observed in heart. 
Despite this, the correlation between EPA levels in blood and these organs was generally high.  
 
The n-3 fatty acids in most body tissues were strongly correlated with these fatty acids in the 
blood markers, the phospholipids in plasma and erythrocytes. The correlation coefficient for all 
n-3 fatty acids was in a range of r=0.85-1 between plasma and tissues (liver, kidney, heart and 
quadriceps muscle) and r=0.75-0.99 between erythrocytes and the tissues. Although all n-3 
LCPUFA levels between blood and tissues examined here were closely related, the correlations 
were somewhat lower for DHA than other n-3 LCPUFA. We hypothesized that this may due in 
part to the curvilinear nature of the DHA data, and the very small range in levels of DHA in 
blood and tissues. The strong correlations between blood and heart that we observed in this 
animal study are consistent with a recent paper from our group in which we demonstrated a close 
relationship between blood and myocardial n-3 fatty acid over a range of intakes of vegetable oil 
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and fish oil in 61 subjects who were undergoing cardiac bypass surgery [32]. The data showed 
strong correlations between plasma or erythrocyte n-3 fatty acids with atrial n-3 fatty acids most 
notably r=0.87-0.93 for EPA, r=0.72-0.78 for DHA and r=0.80-0.85 for the Omega-3 Index [32]. 
 
In general, the n-6 fatty acids in blood highly correlated with the levels in all body organs. We 
found significant correlation coefficient between blood and heart LA (r=0.66-0.7) and AA 
(r=0.94-0.95). However, there was no correlation between LA levels in blood and LA in 
quadriceps muscle. Moreover, although the correlations in LA levels between blood and heart 
were significant, the correlation coefficients were weaker than in other tissues, perhaps due to the 
fact that LA levels in quadriceps muscle and heart only changed modestly with diet. The present 
results are supported by previous reports suggesting that skeletal muscle and heart have similar 
fatty acid profiles which respond similarly to dietary changes [33, 34]. Interestingly, Baur et. al. 
[35] could detect no correlation between muscle LA and erythrocyte LA levels in 61 young 
children undergoing elective surgery, despite a significant positive correlation between muscle 
and erythrocyte total n-3 fatty acids. In our earlier human study [32], blood n-6 fatty acids were 
significantly correlated with the corresponding atrial fatty acids with LA of r=0.64-0.69 and AA 
of r=0.39-0.45.    
 
One of the common questions relating to the fatty acids in blood fractions as biomarkers is 
whether plasma or erythrocyte phospholipid fatty acids are the more accurate predictors of tissue 
LCPUFA levels. Our results suggest that there were no general trends of plasma phospholipid 
fatty acids being a better marker for predicting tissue LCPUFA levels than erythrocyte 
phospholipid fatty acids, except in the kidney where erythrocyte phospholipid PUFA and 
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LCPUFA showed stronger correlations with kidney phospholipid fatty acids than those in the 
plasma. The reason is not clear. However, such tissue specific correlation patterns were not 
applied to other organ tissues. Our results are consistent with the work of Skeaff et. al. [36] who 
showed a high correlation between plasma and erythrocyte fatty acid levels following dietary-
induced changes over a short term (19-day) period. It has been suggested that the levels of 
individual fatty acids in plasma reflected those in erythrocytes in humans [37]. Baylin et. al. [38] 
observed high correlation coefficient between whole blood ALA and LA and the two PUFA in 
plasma. Similar findings have been reported by others [39, 40], suggesting high relationships 
between the blood fractions. The high correlation between the two blood fractions is explained 
by ready exchange of phospholipids between plasma and erythrocytes [41]. In general, the 
measuring erythrocyte phospholipid fatty acids, provides no clear advantage over plasma 
phospholipid fatty acids in most of organ tissues examined in this study. 
 
DHA and AA are the two most abundant LCPUFA in the mammalian brain. In this study, the 
correlations between most phospholipid fatty acids in brain and plasma or erythrocyte fatty acids 
were slightly weaker and variable (r=~0.5-0.9) compared to the same fatty acids observed in 
other peripheral tissues. It has been reported that liver phospholipid DHA and AA with those in 
the brain of newborn infants during normal human development was correlated (r=0.83, 
P<0.001), suggesting liver may be capable of providing the fatty acids required by the 
developing brain [42]. Our rat data show significant correlations in DHA or AA levels between 
blood and brain (r=0.65-0.75), and also between liver and brain (r=0.73-0.79, P<0.0001, data not 
shown in the tables). It has been shown that both plasma and erythrocyte DHA levels were 
significantly correlated with brain DHA levels in the piglets fed with dietary DHA, despite the 
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correlation coefficient value was lower for the correlation between blood and brain than in other 
tissues [43]. Data here are consistent with other reports showing that brain membrane lipids are 
alterable by the type and amount of fatty acids in the diet, however, brain is more resistant to 
dietary fatty acid manipulation than are other tissues [15, 44]. Moreover, The involvement of the 
blood-brain barrier provides a protective barrier between the blood and the extracellular 
environment of the brain and therefore made lipid transportation into cells more complicated 
[45].  
 
In conclusion, we have demonstrated that there are strong correlations between the phospholipid 
fatty acid composition of plasma and erythrocytes and those in the majority of organ tissues 
evaluated in this study in rats following a 3-week dietary ALA intervention. Both plasma and 
erythrocyte phospholipids were indicative of the tissue n-3 LCPUFA content of tissues across the 
wide range of n-3 fatty acid levels. Our finding are particular important for feeding studies 
involving rodents but can also be applied to farmed animals fed ALA rich diets in substitute for 
fish oil and fish meal in the diets.  
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Figure 1. Proportions of phospholipid EPA (A), DPA (B), DHA (C) and AA (D) in 
plasma, erythrocytes, liver, kidney, heart, quadriceps muscle and brain of rats fed a range 
of diets with ALA levels ranging from 0.2-2.9%en. Data points are means ± SEM, n=5 
per group.  
 
Figure 2. Correlations of phospholipid EPA (A and E), DPA (B and F), DHA (C and G) 
and Omega-3 Index (D and H) between plasma or erythrocyte and organ tissues of rats 
fed a range of ALA diets, n=25. 
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Table 1 Correlations between liver phospholipid fatty acids and corresponding plasma and 























P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****























ALA -0.00 + 0.65X 1.00****2 -0.03 + 0.89X 0.99**** 0.1502 
EPA -0.04 + 2.68X 0.99**** 0.26 + 1.85X 0.99**** 0.4520 
DPA -0.02 + 1.34X 1.00**** -0.57 + 0.57X 0.98**** 0.0001 
DHA 2.03 + 1.47X 0.96**** -1.90 + 3.67X 0.90**** 0.0113 
EPA+DHA -0.74 + 2.12X 0.97**** 1.50 + 2.36X 0.98**** 0.4691 
Total n-3 
LCPUFA 
-0.54 + 2.03X 0.98**** 1.18 + 1.76X 0.99**** 0.2907 
Total n-3 -0.17 + 1.93X 0.99**** 1.42 + 1.70X 0.98**** 0.7435 
LA 3.76 + 0.34X 0.80**** 0.77 + 1.26X 0.88**** 0.0452 
AA 1.48 + 1.47X 0.98**** -16.14 + 1.69X 0.99**** 0.3008 
Total n-6 -49.33 + 3.20X 0.82**** -17.22 + 1.61X 0.98**** <.0001 
Total Monos 1.89 + 0.78X 0.95**** -2.48 + 1.02X 0.81**** 0.0007 
Total 
Saturates 




Table 2 Correlations between kidney phospholipid fatty acids and corresponding plasma and 























P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****























ALA 0.04 + 0.74X 0.98****2 0.01 + 1.03X 0.99**** 0.0441 
EPA -0.20 + 1.71X 0.97**** -0.08 + 1.21X 0.99**** 0.0012 
DPA 0.09 + 0.72X 0.98**** -0.22 + 0.31X 0.99**** 0.2345 
DHA 1.40 + 0.25X 0.89**** 0.72 + 0.62X 0.83**** 0.2536 
EPA+DHA -1.41 + 0.95X 0.88**** -1.10 + 1.17X 0.99**** <.0001 
Total n-3 
LCPUFA 
-1.48 + 0.95X 0.92**** -1.20 + 0.89X 0.99**** <.0001 
Total n-3 -1.58 + 0.96X 0.94**** -1.25 + 0.90X 0.99**** <.0001 
LA 1.85 + 0.59X 0.88**** -2.47 + 2.04X 0.91**** 0.4351 
AA 10.82 + 1.26X 0.93**** -5.52 + 1.52X 0.98**** 0.0021 
Total n-6 -11.96 + 1.94X 0.66*** 3.14 + 1.15X 0.93**** <.0001 
Total Monos 12.82 + 0.22X 0.58** 10.32 + 0.36X 0.61** 0.7448 
Total 
Saturates 
37.07 + 0.13X 0.29 38.59 + 0.10X 0.15 0.5035 
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Table 3 Correlations between heart phospholipid fatty acids and corresponding plasma and 























P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****






















P value Comparing 
Plasma and  
Erythrocyte  
Correlations 
ALA 0.07 + 0.88X 0.97****2 0.02 + 1.22X 0.99**** 0.0077 
EPA 0.02 + 0.46X 0.97**** 0.06 + 0.33X 0.99**** 0.0735 
DPA 0.37 + 1.76X 0.99**** -0.39 + 0.76X 0.99**** 0.8198 
DHA 1.66 + 1.27X 0.89**** -1.37 + 3.06X 0.80**** 0.0555 
EPA+DHA 2.22 + 1.00X 0.96**** 3.74 + 1.04X 0.89**** 0.0259 
Total n-3 
LCPUFA 
2.10 + 1.13X 0.97**** 3.32 + 0.95X 0.94**** 0.1696 
Total n-3 2.06 + 1.12X 0.97**** 3.17 + 0.97X 0.95**** 0.1219 
LA 10.59 + 0.47X 0.66*** 6.89 + 1.67X 0.70**** 0.5237 
AA 10.37 + 0.93X 0.94**** -0.63 + 1.06X 0.95**** 0.9046 
Total n-6 -5.49 + 1.82X 0.77**** 13.68 + 0.88X 0.88**** 0.0756 
Total Monos 3.02 + 0.66X 0.79**** -7.27 + 1.23X 0.96**** <.0001 
Total 
Saturates 
16.75 + 0.42X 0.47* 20.91 + 0.35X 0.26 0.2751 
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Table 4 Correlations between brain phospholipid fatty acids and corresponding plasma and 




























ND, not detected. 
3*
P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****














P value Comparing 
Plasma and  
Erythrocyte  
Correlations 
ALA ND2 ND ND ND . 
EPA 0.03 + 0.01X 0.52**3 0.03 + 0.01X 0.53** 0.7397 
DPA 0.07 + 0.22X 0.95**** -0.03 + 0.10X 0.95**** 0.8886 
DHA 12.27 + 0.58X 0.75**** 11.06 + 1.35X 0.65*** 0.1231 
EPA+DHA 13.19 + 0.32X 0.71**** 14.05 + 0.27X 0.53** 0.0100 
Total n-3 
LCPUFA 
13.40 + 0.30X 0.74**** 14.07 + 0.21X 0.60** 0.0094 
Total n-3 13.58 + 0.26X 0.71**** 14.15 + 0.19X 0.59** 0.0078 
LA 0.19 + 0.02X 0.91**** -0.00 + 0.09X 0.96**** 0.0389 
AA 7.47 + 0.15X 0.72**** 5.74 + 0.17X 0.73**** 0.9791 
Total n-6 2.02 + 0.44X 0.54** 5.91 + 0.24X 0.71**** 0.0924 
Total Monos 18.89 + -0.03X -0.06 21.42 + -0.17X -0.24 0.1263 
Total Saturates 52.41 + 0.02X 0.05 64.11 + -0.23X -0.38 0.0380 
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Table 5 Correlations between quadriceps muscle phospholipid fatty acids and corresponding 























P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****




















P value Comparing 
Plasma and  
Erythrocyte  
Correlations 
ALA 0.28 + 1.67X 0.97****2 0.19 + 2.33X 0.99**** 0.0169 
EPA 0.11 + 0.87X 0.96**** 0.18 + 0.61X 0.98**** 0.2381 
DPA 0.72 + 2.71X 0.99**** -0.44 + 1.17X 0.99**** 0.4777 
DHA 1.45 + 1.20X 0.85**** -1.29 + 2.86X 0.75**** 0.0724 
EPA+DHA 0.85 + 1.22X 0.96**** 2.29 + 1.33X 0.95**** 0.5259 
Total n-3 
LCPUFA 
0.60 + 1.47X 0.96**** 1.81 + 1.28X 0.97**** 0.4182 
Total n-3 0.38 + 1.53X 0.97**** 1.53 + 1.36X 0.98**** 0.4517 
LA 16.07 + 0.05X 0.19 15.47 + 0.22X 0.24 0.5568 
AA 4.71 + 0.62X 0.94**** -2.87 + 0.72X 0.96**** 0.2509 
Total n-6 -15.15 + 1.93X 0.76**** 2.54 + 1.03X 0.97**** <.0001 
Total Monos 3.17 + 0.89X 0.76**** -12.13 + 1.75X 0.96**** <.0001 
Total 
Saturates 
36.34 + 0.04X 0.08 36.56 + 0.04X 0.05 0.8899 
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P < 0.05, 
**
P < 0.01, 
***
P < 0.001 and 
****


















ALA -0.04 + 0.72X 0.99****2 
EPA -0.08 + 1.40X 0.97**** 
DPA 1.02 + 2.27X 0.98**** 
DHA 1.44 + 0.33X 0.90**** 
EPA+DHA -0.38 + 0.82X 0.91**** 
Total n-3 
LCPUFA 
-0.49 + 1.09X 0.94**** 
Total n-3 -0.49 + 1.08X 0.95**** 
LA 2.28 + 0.28X 0.93**** 
AA 10.80 + 0.83X 0.95**** 
Total n-6 -18.00 + 1.90X 0.80**** 
Total Monos 8.16 + 0.548X 0.84**** 
Total 
Saturates 
30.59 + 0.33X 0.5* 
